Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Boxed, Inc. (“Boxed” or the “Company”) (NYSE: BOXD). Such investors are advised to...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Luminar Technologies, Inc. (“Luminar” or the “Company”) (NASDAQ: LAZR). Such investors...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Groupon. (“Groupon” or the “Company”) (NASDAQ: GRPN). Such investors are advised to...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tupperware Brands Corporation (“Tupperware” or the “Company”) (NYSE: TUP). Such investors...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fox Corporation (“Fox” or the “Company”) (NASDAQ: FOX; FOXA). Such investors are advised...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN). Such investors are...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rite Aid Corporation (“Rite Aid” or the “Company”) (NYSE: RAD). Such investors are...
-
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Array Technologies, Inc. (“Array” or the “Company”) (NASDAQ: ARRY). Such investors are...
-
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medical Properties Trust, Inc. (“MPT” or the “Company”) (NYSE: MPW). Such investors are...